Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Incyte Corporation
MOMA Therapeutics
Exelixis
OHSU Knight Cancer Institute
Canadian Cancer Trials Group
AstraZeneca
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AstraZeneca
The Christie NHS Foundation Trust